结肠癌确诊至手术时间对生存的影响:全国趋势分析
基于美国国家癌症数据库2006-2021年46,392例I-III期结肠腺癌患者,分析确诊至手术时间与生存的关系。手术时间分为早期(14-48天)、中期(49-69天)和晚期(70-90天),5年总生存率分别为77%、73%和67%。与早期手术相比,中期和晚期手术与更差的总生存独立相关。
要点
- 结肠癌确诊至手术≤48天与更好的5年总生存相关。
- 手术延迟至49-69天和70-90天,死亡风险分别增加30%和60%。
- 健康状态好、分期晚及医疗可及性好的患者更可能早期手术。
核心结论
- 结肠癌确诊至手术时间≤48天与改善的5年总生存相关,手术延迟与更差生存独立相关。
研究设计与样本
- 回顾性队列研究,查询美国国家癌症数据库2006-2021年数据。
- 纳入46,392例接受 upfront 结肠切除术的临床I-III期结肠腺癌成人患者,手术距诊断14-90天。
- 排除手术距诊断<14天、接受新辅助治疗或随访数据缺失的患者。
主要发现
- 86%患者为早期手术(14-48天),11%为中期(49-69天),4%为晚期(70-90天)。
- 早期、中期、晚期手术的5年总生存率分别为77%、73%和67%。
- 与早期手术相比,中期手术风险比1.30(95%CI 1.20-1.39),晚期手术风险比1.60(95%CI 1.44-1.79)。
- 白人种族、私人保险、较低Charlson-Deyo评分和较晚肿瘤分期与早期手术几率增加相关(所有P<.01)。
临床怎么用
- 在临床实践中应关注结肠癌确诊至手术的时间间隔,尽量在48天内完成手术。
- 对于存在手术延迟风险的患者,可考虑质量改进措施以确保及时手术干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While it is generally accepted that delays in oncologic care negatively impact patients' outcomes, the optimal time to surgery for colon cancer is not established. The aim of this study was to assess the impact of time to surgery on survival in stage I-III colon cancer. METHODS: The National Cancer Database was queried for adults who underwent upfront colectomy for clinical stage I-III colon adenocarcinoma 14-90 days from diagnosis (2006-2021). Patients with time to surgery <14 days (a surrogate for emergency cases), neoadjuvant therapy, or missing follow-up data were excluded. Time to surgery was grouped into early (14-48 days), middle (49-69), and late (70-90) intervals based on clusters of similar survival outcomes for final multivariable models. RESULTS: Of 46,392 patients (52% female, 61% age ≥65, 84% White, 68% Charlson-Deyo score 0, 50% stage I), 86% underwent surgery in the early interval, 11% in the middle interval, and 4% in the late interval. White race, private insurance, lower Charlson-Deyo score, and later-stage tumors were associated with increased odds of early time to surgery (all P < .01). Five-year overall survival was 77% for early, 73% for middle, and 67% for late intervals. Delayed surgery was associated with worse 5-year overall survival compared with early surgery (middle hazard ratio, 1.30; 95% confidence interval, 1.20-1.39; late hazard ratio, 1.60; 95% confidence interval, 1.44-1.79). CONCLUSION: Improved survival was noted in those with time to surgery ≤48 days. Healthy patients, higher stage disease, and sociodemographic characteristics typically associated with improved access to health care were associated with early time to surgery. These results highlight a potential opportunity to define benchmark time to surgery and identify areas for quality improvement to ensure timely surgical intervention.
引用
- Frebault J, Mott SL, Tran C, et al. Defining the impact of time to surgery on survival after colon cancer diagnosis: A national trend analysis. Surgery. 2026. PMID: 42791095. doi:10.1016/j.surg.2026.110611
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。